All News     |   Press Releases     |   Newsletters     |   Blog

News

Read all of the latest news, press releases, newsletters, and blog posts. Choose a link above to filter by category.

    • 07 MAR 17
    • 0

    LATTICE BIOLOGICS EXTENDS PRIVATE PLACEMENT

    NOT FOR DISSEMINATION IN THE US OR THROUGH US NEWSWIRE SERVICES March 7, 2017 – Scottsdale, AZ – Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) (“Lattice Biologics” or the “Company”) announces that it is extending its non-brokered private placement of Units of the Company (“Units“), announced on January 19, 2017 (the “Offering“), for an additional

    Read more →
    • 01 MAR 17
    • 0

    LATTICE BIOLOGICS LTD. REPORTS FIRST QUARTER 2017 HIGHLIGHTS

    Record Gross Margin of 36.6% or $326,620 March 1, 2017 – Scottsdale, AZ – Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) (“Lattice Biologics” or the “Company”) announces financial results for the first quarter ended December 31, 2016: Highlights: Record Gross Margins increased 44% Q1 2017 over Q1 2016 Continued sales focus to higher margin product

    Read more →
    • 28 FEB 17
    • 0

    LATTICE BIOLOGICS PARTICIPATES IN $300 MILLION PUBLIC-PRIVATE INITIATIVE, THE ADVANCED REGENERATIVE MANUFACTURING INSTITUTE (ARMI)

    Initiative aims to develop scalable manufacturing processes for engineered tissue and organs February 28, 2017 – Scottsdale, AZ – Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) (“Lattice Biologics” or the “Company”) is pleased to announce that it is part of a new public-private initiative, the Advanced Regenerative Manufacturing Institute (“ARMI“). ARMI will receive approximately $80

    Read more →
    • 28 FEB 17
    • 0

    LATTICE BIOLOGICS CLOSES FOURTH TRANCHE OF PRIVATE PLACEMENT ANNOUNCED ON JANUARY 19, 2017

    NOT FOR DISSEMINATION IN THE US OR THROUGH US NEWSWIRE SERVICES February 28, 2017 – Scottsdale, AZ – Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) (“Lattice Biologics” or the “Company”) is pleased to announce that it has closed the fourth tranche of its non-brokered private placement of Units of the Company (“Units“) announced on January 19,

    Read more →
    • 16 FEB 17
    • 0

    LATTICE BIOLOGICS CLOSES THIRD TRANCHE OF PRIVATE PLACEMENT ANNOUNCED ON JANUARY 19, 2017

    February 16th, 2017 – Scottsdale, AZ – Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) (“Lattice Biologics” or the “Company“) is pleased to announce that it has closed the third tranche of its non-brokered private placement of Units of the Company (“Units“) announced on January 19, 2017 (the “Offering“). The Company has issued 658,260 Units at

    Read more →
    • 14 FEB 17
    • 0

    NOTICE OF LATTICE BIOLOGICS LTD. FIRST QUARTER 2017 FINANCIAL RESULTS CONFERENCE CALL

    Financial results to be released after market on Wednesday, March 1, 2017 February 14, 2017 – SCOTTSDALE – Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) (the “Company“) announced today that it will release its first quarter 2017 financial results after market on Wednesday, March 1, 2017. Following this, Guy Cook, Chief Executive Officer, and Cheryl Farmer, Chief Financial

    Read more →
    • 30 JAN 17
    • 0

    LATTICE BIOLOGICS LTD. REPORTS FOURTH QUARTER AND YEAR END 2016 HIGHLIGHTS

    New core product sales increase 147% fourth quarter over fourth quarter January 30, 2017 – Scottsdale, AZ – Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) (“Lattice Biologics” or the “Company”) announces financial results for the fourth quarter and year ended September 30, 2016: Highlights: DBM Putty growth 620% Q4 2016 over Q4 2015 Acellular Dermal

    Read more →
    • 27 JAN 17
    • 0

    NOTICE OF LATTICE BIOLOGICS LTD. YEAR END 2016 FINANCIAL RESULTS CONFERENCE CALL

    Financial results to be released after market on Monday, January 30, 2017 January 27, 2017 – Scottsdale, AZ – Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) (the “Company”) announced today that it will release its year ended September 30, 2016 financial results after market on Monday, January 30, 2017. Following this, Guy Cook, Chief Executive

    Read more →

Recent Events